Abstract:Canavan disease is an autosomal recessive leukodystrophy caused by mutations in the gene encoding aspartoacylase (ASPA), which hydrolyses N-acetylaspartate (NAA) to acetate and aspartate. A similar feline neurodegenerative disease associated with a mutation in the ASPA gene is reported herein. Comprehensive clinical, genetic, and pathological analyses were performed on 4 affected cats. Gait disturbance and head tremors initially appeared at 1 to 19 months of age. These cats eventually exhibited dysstasia and seizures and died at 7 to 53 months of age. Magnetic resonance imaging of the brain revealed diffuse symmetrical intensity change of the cerebral cortex, brainstem, and cerebellum. Gas chromatography–mass spectrometry analysis of urine showed significant excretion of NAA. Genetic analysis of the 4 affected cats identified a missense mutation (c.859G>C) in exon 6 of the ASPA gene, which was not detected in 4 neurologically intact cats examined as controls. Postmortem analysis revealed vacuolar changes predominantly distributed in the gray matter of the cerebrum and brain stem as well as in the cerebellar Purkinje cell layer. Immunohistochemically, these vacuoles were surrounded by neurofilaments and sometimes contained MBP- and Olig2-positive cells. Ultrastructurally, a large number of intracytoplasmic vacuoles containing mitochondria and electron-dense granules were detected in the cerebral cortex. All 4 cats were diagnosed as spongy encephalopathy with a mutation in the ASPA gene, a syndrome analogous to human Canavan disease. The histopathological findings suggest that feline ASPA deficiency induces intracytoplasmic edema in neurons and oligodendrocytes, resulting in spongy degeneration of the central nervous system.

A novel Aspartoacylase (ASPA) Gene Mutation in Canavan Disease

Clinical and Aspartoacylase Gene Mutation Analysis of Canavan Disease in a Child

Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease

A Novel Disease-Causing ASPA Gene Mutation (c.432+1 G>C) in an Iranian Patient with Canavan Disease: A Case Report

Analysis of Aspartoacylase Gene Mutations in One Chinese Family with Canavan Disease

A Novel Mutation in Aspartoacylase Gene; Canavan Disease

A missense mutation (p.G274R) in gene ASPA causes Canavan disease in a Pakistani family

Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease

New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion

Evolutionarily conserved chaperone-mediated proteasomal degradation of a disease-linked aspartoacylase variant

Two novel missense mutations in the aspartoacylase gene in a Chinese patient with congenital Canavan disease.

Novel mutation in an Egyptian patient with infantile Canavan disease

Two patients with Canavan disease and structural modeling of a novel mutation

Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Canavan disease]

Structural modeling of p.V31F variant in the aspartoacylase gene

Feline Spongy Encephalopathy With a Mutation in the ASPA Gene

Severe retinal degeneration in a patient with Canavan disease

Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme

The pathogenesis of, and pharmacological treatment for, Canavan disease

Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI